DK176487A - Middel til behandling af inflammationer i oejet - Google Patents

Middel til behandling af inflammationer i oejet

Info

Publication number
DK176487A
DK176487A DK176487A DK176487A DK176487A DK 176487 A DK176487 A DK 176487A DK 176487 A DK176487 A DK 176487A DK 176487 A DK176487 A DK 176487A DK 176487 A DK176487 A DK 176487A
Authority
DK
Denmark
Prior art keywords
inflammation
eye
treatment
Prior art date
Application number
DK176487A
Other languages
English (en)
Other versions
DK164639B (da
DK164639C (da
DK176487D0 (da
Inventor
Johann Doulakas
Original Assignee
Dispersa Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6298657&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK176487(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dispersa Ag filed Critical Dispersa Ag
Publication of DK176487D0 publication Critical patent/DK176487D0/da
Publication of DK176487A publication Critical patent/DK176487A/da
Publication of DK164639B publication Critical patent/DK164639B/da
Application granted granted Critical
Publication of DK164639C publication Critical patent/DK164639C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK176487A 1986-04-14 1987-04-07 Middel til behandling af inflammationer i oejet samt fremgangsmaade til fremstilling heraf DK164639C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3612537 1986-04-14
DE3612537A DE3612537C1 (de) 1986-04-14 1986-04-14 Arzneimittel zur Behandlung von Entzuendungen im Auge

Publications (4)

Publication Number Publication Date
DK176487D0 DK176487D0 (da) 1987-04-07
DK176487A true DK176487A (da) 1987-10-15
DK164639B DK164639B (da) 1992-07-27
DK164639C DK164639C (da) 1992-12-21

Family

ID=6298657

Family Applications (1)

Application Number Title Priority Date Filing Date
DK176487A DK164639C (da) 1986-04-14 1987-04-07 Middel til behandling af inflammationer i oejet samt fremgangsmaade til fremstilling heraf

Country Status (12)

Country Link
US (1) US4829088A (da)
EP (1) EP0242328B1 (da)
JP (1) JP2515788B2 (da)
CA (1) CA1286225C (da)
DE (1) DE3612537C1 (da)
DK (1) DK164639C (da)
EG (1) EG18268A (da)
ES (1) ES2038691T4 (da)
GR (1) GR3002659T3 (da)
NO (1) NO174916C (da)
PT (1) PT84669B (da)
ZA (1) ZA872624B (da)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH675537A5 (da) * 1988-03-25 1990-10-15 Ciba Geigy Ag
US4960799A (en) * 1988-09-13 1990-10-02 Ciba-Geigy Corporation Stabilized aqueous solutions of pharmaceutically acceptable salts of ortho-(2,6-dichlorophenyl)-aminophenylacetic acid for opthalmic use
ATE103182T1 (de) * 1989-09-21 1994-04-15 Ciba Vision Ag Antimikrobielle zusammensetzungen.
US6117907A (en) * 1993-04-14 2000-09-12 Sher; Neal A. Topical treatment of ocular pain after corneal surgery
US5494817A (en) * 1993-12-06 1996-02-27 Allergan, Inc. Sugar-based protease composition for use with constant-PH borate buffers
US5474985A (en) * 1993-12-22 1995-12-12 The Regents Of The University Of California Preventing and treating elevated intraocular pressure associated with administered or endogenous steroids using non-steroidal cyclooxygenase inhibitors
ES2079320B1 (es) * 1994-05-17 1996-10-16 Cusi Lab Disolucion oftalmica a base de un diclofenaco y tobramicina y sus aplicaciones.
US6309630B1 (en) 1994-05-24 2001-10-30 Insite Vision Incorporated Non-steroidal anti-inflammatory ophthalmic suspensions
US5849879A (en) * 1994-11-03 1998-12-15 The Regents Of The University Of California Methods for the diagnosis of glaucoma
US5606043A (en) 1994-11-03 1997-02-25 The Regents Of The University Of California Methods for the diagnosis of glaucoma
US5789169A (en) * 1994-11-03 1998-08-04 Regents Of The University Of California Methods for the diagnosis of glaucoma
DE69526369T2 (de) * 1995-01-20 2002-11-07 Wakamoto Pharmaceutical Co., Ltd. Entzündungshemmende augentropfen
JP3170619B2 (ja) * 1995-04-20 2001-05-28 参天製薬株式会社 有機アミンを配合したプラノプロフェン点眼液
US5620970A (en) * 1995-06-05 1997-04-15 Alcon Laboratories, Inc. Topical ophthalmic carbonic anhydrase inhibitor formulations
US5599535A (en) * 1995-06-07 1997-02-04 Regents Of The University Of California Methods for the cyto-protection of the trabecular meshwork
US5674888A (en) * 1995-06-07 1997-10-07 University Of California Method for the treatment of a trabecular meshwork whose cells are subject to inhibition of cell division
US5686488A (en) * 1995-08-25 1997-11-11 Alcon Laboratories, Inc. Polyethoxylated castor oil products as anti-inflammatory agents
CA2241515A1 (en) * 1995-12-27 1997-07-10 Junko Shima Aqueous composition comprising cromoglycic acid
US5814655A (en) * 1996-11-14 1998-09-29 Insite Vision Incorporated Non-steroidal ophthalmic mixtures
PT1190718E (pt) * 1996-12-13 2006-08-31 Alcon Lab Inc Composicoes oftalmicas contendo aminoalcoois
US6475724B1 (en) 1997-01-28 2002-11-05 The Regents Of The University Of California Nucleic acids, kits, and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
US6171788B1 (en) 1997-01-28 2001-01-09 The Regents Of The University Of California Methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
US7138511B1 (en) 1997-01-28 2006-11-21 The Regents Of The University Of California Nucleic acids, kits and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
US6265444B1 (en) 1997-05-23 2001-07-24 Insite Vision Incorporated Ophthalmic composition
DE19729879C2 (de) * 1997-07-11 1999-07-08 Mann Gerhard Chem Pharm Fab Lagerstabile ophthalmische Zusammensetzungen, umfassend Diclofenac und Ofloxacin
JP2006111636A (ja) * 1997-12-26 2006-04-27 Astellas Pharma Inc 徐放性医薬組成物
AU1548001A (en) * 1999-11-24 2001-06-04 Wakamoto Pharmaceutical Co., Ltd. Ophthalmic aqueous preparation
PE20020146A1 (es) * 2000-07-13 2002-03-31 Upjohn Co Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2)
US20030119000A1 (en) * 2001-11-05 2003-06-26 Jon Polansky Methods to screen and treat individuals with glaucoma or the propensity to develop glaucoma
TW200304812A (en) * 2002-03-08 2003-10-16 Sankyo Co An eye drop containing a tetrazole derivative
US20050119299A1 (en) * 2002-03-08 2005-06-02 Sankyo Company, Limited Ophthalmic solutions containing tetrazole derivatives
JP4524538B2 (ja) * 2002-04-08 2010-08-18 ライオン株式会社 眼科用組成物
US20040224010A1 (en) * 2002-11-15 2004-11-11 Optime Therapeutics, Inc. Ophthalmic liposome compositions and uses thereof
AR042206A1 (es) 2002-11-26 2005-06-15 Novartis Ag Acidos fenilaceticos y derivados
PL1808170T3 (pl) * 2004-11-05 2011-12-30 Senju Pharma Co Wodne krople do oczu z przyśpieszoną migracją wewnątrzgałkową
WO2006058022A1 (en) 2004-11-24 2006-06-01 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
US8758816B2 (en) * 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
US20070020330A1 (en) 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
JP5108234B2 (ja) * 2005-02-07 2012-12-26 日本特殊陶業株式会社 マイクロヒータ及びセンサ
US20100130580A1 (en) * 2006-01-25 2010-05-27 Aciex Therapeutics, Inc. Formulations and Methods for Treating Dry Eye
WO2007087609A2 (en) * 2006-01-25 2007-08-02 Aciex, Inc. Formulations and methods for treating dry eye
US20070212420A1 (en) * 2006-03-10 2007-09-13 Bausch & Lomb Incorporated Pharmaceutical formulations comprising polyanionic materials and zinc-based preservatives
US7829249B2 (en) * 2007-03-05 2010-11-09 Asml Netherlands B.V. Device manufacturing method, computer program and lithographic apparatus
TWI465236B (zh) * 2007-03-13 2014-12-21 參天製藥股份有限公司 含有吡諾克辛之懸浮型水性液劑
JP2010528014A (ja) * 2007-05-24 2010-08-19 アーシエックス セラピューティックス， インコーポレイテッド ドライアイを処置するための処方物および方法
US20130011469A1 (en) 2009-07-23 2013-01-10 U.S. Nutraceuticals, Llc D/B/A Valensa International Krill oil and carotenoid composition, associated method and delivery system
JP5246182B2 (ja) * 2010-02-24 2013-07-24 ライオン株式会社 点眼剤、防腐剤及び防腐力向上剤
JP5299449B2 (ja) * 2011-02-23 2013-09-25 ライオン株式会社 外用剤組成物
JP2013082682A (ja) * 2011-09-29 2013-05-09 Senju Pharmaceut Co Ltd 亜塩素酸塩を含有する水性製剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU185926B (en) * 1979-09-27 1985-04-28 Agostne Kahan Process for preparing water soluble derivatives of non-steroid antiinflammatory compositions and pharmaceutical compositins containing such derivatives
DE3026402A1 (de) * 1980-07-11 1982-02-04 Syntex Corp., Palo Alto, Calif. Die verwendung analgetischer und nicht-hormonaler, entzuendungshemmender mittel bei der behandlung von mikrovaskulaeren erkrankungen
JPS58174310A (ja) * 1982-04-06 1983-10-13 Wakamoto Pharmaceut Co Ltd 抗炎症点眼剤
JPS58174309A (ja) * 1982-04-06 1983-10-13 Wakamoto Pharmaceut Co Ltd 消炎点眼剤

Also Published As

Publication number Publication date
DK164639B (da) 1992-07-27
ES2038691T4 (es) 1995-09-01
PT84669A (en) 1987-05-01
EP0242328A3 (en) 1988-04-06
JPS62242617A (ja) 1987-10-23
US4829088A (en) 1989-05-09
ZA872624B (en) 1987-12-30
NO871549D0 (no) 1987-04-13
DE3612537C1 (de) 1987-07-16
NO871549L (no) 1987-10-15
DK164639C (da) 1992-12-21
JP2515788B2 (ja) 1996-07-10
EP0242328B1 (de) 1991-07-24
GR3002659T3 (en) 1993-01-25
NO174916C (no) 1994-08-03
EP0242328A2 (de) 1987-10-21
CA1286225C (en) 1991-07-16
DK176487D0 (da) 1987-04-07
ES2038691T3 (es) 1993-08-01
NO174916B (no) 1994-04-25
PT84669B (pt) 1989-11-30
EG18268A (en) 1993-02-28

Similar Documents

Publication Publication Date Title
DK176487D0 (da) Middel til behandling af inflammationer i oejet
DK36491D0 (da) Praeparat til behandling af erektiv dysfunktion
DK63688D0 (da) Fremgangsmaade til behandling af affald
FI874671A (fi) Anordning foer foerhindrande av laeckage i tryckledningar.
DK530287A (da) Fremgangsmaade til behandling af spildevand
DK728688D0 (da) Middel til nedsaettelse af blodcholesterolniveauet
DK119587A (da) Fremgangsmaade til vaeskebehandling
DK369385A (da) Middel til behandling af schizofreni
DK101197A (da) Medikament til behandling af thrombocytopenia
DK461686D0 (da) Middel til behandling af mave- og tarmkanalforstyrrelser
DK298187A (da) Applikator til behandling af laeber
DK631989D0 (da) Anti-plakmiddel og/eller middel til behandling af lidelser i mundhulen
DK68784A (da) Kontinuert fremgangsmaade til fremstilling af 5-oxo-2,4-dichlor-4-substituerede pentannitriler
NO920983D0 (no) Fremgangsmaate for behandling av nevrodegenerative tilstander
DK632388D0 (da) Pharmaceutisk middel til behandling af hypolipidaemi hos pattedyr
DK250288A (da) Middel til oploesning af svovl
DK322683D0 (da) Middel til behandling af sar
DK216687A (da) Fremgangsmaade til fremstilling af middel til be- handling af roeggas
DK160821C (da) 1,3-dihydro-4-benzoyl-2h-imidazol-2-oner samt middel til behandling af hjertesvigt
DK524588A (da) Middel til behandling af aids
DK162146C (da) Pesticidt middel til behandling af trae
DK184687A (da) Fremgangsmaade til fremstilling af diacetonesorbose
DK551683D0 (da) Middel til behandling af gastroinflammationssygdomme
DK460187A (da) Fremgangsmaade til fremstillling af optisk aktive beta-lactamer
DK163865C (da) Anvendelse af oestrogener til fremstilling af praeparater til lokal anvendelse til behandling af forhoejet tryk i oejet